BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Misra S, Chaturvedi A, Misra NC, Sharma ID. Carcinoma of the gallbladder. Lancet Oncol. 2003;4:167-176. [PMID: 12623362 DOI: 10.1016/s1470-2045(03)01021-0] [Cited by in Crossref: 431] [Cited by in F6Publishing: 188] [Article Influence: 22.7] [Reference Citation Analysis]
Number Citing Articles
1 Hassan EH, Gerges SS, El-Atrebi KA, El-Bassyouni HT. The role of H. pylori infection in gall bladder cancer: clinicopathological study. Tumour Biol. 2015;36:7093-7098. [PMID: 25877756 DOI: 10.1007/s13277-015-3444-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
2 Grobmyer SR, Lieberman MD, Daly JM. Gallbladder cancer in the twentieth century: single institution's experience. World J Surg 2004;28:47-9. [PMID: 14639492 DOI: 10.1007/s00268-003-7131-4] [Cited by in Crossref: 35] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
3 Mallick S, Benson R, Julka PK, Rath GK. Adjuvant chemoradiotherapy for squamous cell carcinoma of gallbladder. J Gastrointest Cancer 2014;45 Suppl 1:237-40. [PMID: 25119385 DOI: 10.1007/s12029-014-9641-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
4 Qin JM. Causes of misdiagnosis and missed diagnosis and therapeutic and preventive strategies for unexpected gallbladder carcinoma. Shijie Huaren Xiaohua Zazhi 2020; 28(23): 1167-1176 [DOI: 10.11569/wcjd.v28.i23.1167] [Reference Citation Analysis]
5 Shioi Y, Osakabe M, Yanagawa N, Nitta H, Sasaki A, Sugai T. Analysis of somatic copy number alterations in biliary tract carcinoma using a single nucleotide polymorphism array. Future Sci OA 2022;8:FSO766. [PMID: 34900340 DOI: 10.2144/fsoa-2021-0057] [Reference Citation Analysis]
6 Kitajima K, Kobayashi S, Shiba H, Uwagawa T, Ishida Y, Aiba K, Kawakami M, Yanaga K. Successful treatment of advanced gallbladder cancer with an anticancer drug S-1: assessment based on intratumoral gene. Int J Clin Oncol. 2008;13:545-551. [PMID: 19093184 DOI: 10.1007/s10147-008-0777-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
7 Zhang SB, Song SP, Li B, Zhou YS, Zhang YD. Expression of N-myc downstream-regulated gene 1 in primary gallbladder carcinoma and its correlation with clinicopathological features and clinical outcome. Med Oncol. 2012;29:1866-1872. [PMID: 21735144 DOI: 10.1007/s12032-011-0017-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
8 Wang P, Zhou C, Li D, Zhang D, Wei L, Deng Y. circMTO1 sponges microRNA-219a-5p to enhance gallbladder cancer progression via the TGF-β/Smad and EGFR pathways. Oncol Lett 2021;22:563. [PMID: 34113391 DOI: 10.3892/ol.2021.12824] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Matsumoto Y, Fujimoto K, Mitsuoka E, Senda E, Shio S, Ichikawa K, Yamada H. Cholecystoduodenal fistula caused by aggressive mucinous gallbladder carcinoma with a porcelain gallbladder. Clin J Gastroenterol 2019;12:460-5. [PMID: 30919282 DOI: 10.1007/s12328-019-00969-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
10 Gabbi C, Kim HJ, Barros R, Korach-Andrè M, Warner M, Gustafsson JA. Estrogen-dependent gallbladder carcinogenesis in LXRbeta-/- female mice. Proc Natl Acad Sci U S A 2010;107:14763-8. [PMID: 20679224 DOI: 10.1073/pnas.1009483107] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
11 Palanisamy S, Patel N, Sabnis S, Palanisamy N, Vijay A, Palanivelu P, Parthasarthi R, Chinnusamy P. Laparoscopic radical cholecystectomy for suspected early gall bladder carcinoma: thinking beyond convention. Surg Endosc. 2016;30:2442-2448. [PMID: 26416372 DOI: 10.1007/s00464-015-4495-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
12 Báez S, Tsuchiya Y, Calvo A, Pruyas M, Nakamura K, Kiyohara C, Oyama M, Yamamoto M. Genetic variants involved in gallstone formation and capsaicin metabolism, and the risk of gallbladder cancer in Chilean women. World J Gastroenterol 2010; 16(3): 372-378 [PMID: 20082485 DOI: 10.3748/wjg.v16.i3.372] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
13 Jiao XY, Lü MD, Huang JF, Liang LJ, Shi JS. Genomic determination of CR1 CD35 density polymorphism on erythrocytes of patients with gallbladder carcinoma. World J Gastroenterol 2004; 10(23): 3480-3484 [PMID: 15526369 DOI: 10.3748/wjg.v10.i23.3480] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
14 Rahul, Haldeniya K, Singh A, Bhatt N, Mishra P, Singh RK, Saxena R. Determinants of curative resection in incidental gallbladder carcinoma with special reference to timing of referral. Ann Hepatobiliary Pancreat Surg 2021;25:492-9. [PMID: 34845121 DOI: 10.14701/ahbps.2021.25.4.492] [Reference Citation Analysis]
15 Zhu AX, Hong TS, Hezel AF, Kooby DA. Current management of gallbladder carcinoma. Oncologist. 2010;15:168-181. [PMID: 20147507 DOI: 10.1634/theoncologist.2009-0302] [Cited by in Crossref: 184] [Cited by in F6Publishing: 164] [Article Influence: 15.3] [Reference Citation Analysis]
16 Tang H, Shi X, Zhu P, Guo W, Li J, Yan B, Zhang S. Melatonin inhibits gallbladder cancer cell migration and invasion via ERK-mediated induction of epithelial-to-mesenchymal transition. Oncol Lett 2021;22:609. [PMID: 34188711 DOI: 10.3892/ol.2021.12870] [Reference Citation Analysis]
17 Zhan M, Zhao X, Wang H, Chen W, Xu S, Wang W, Shen H, Huang S, Wang J. miR-145 sensitizes gallbladder cancer to cisplatin by regulating multidrug resistance associated protein 1. Tumour Biol. 2016;37:10553-10562. [PMID: 26852750 DOI: 10.1007/s13277-016-4957-6] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 6.3] [Reference Citation Analysis]
18 Lee SH, Yang JD, Hwang HP, Yu HC, Cho BH. Surgical outcomes and prognostic factors influencing long-term survival in patients with gallbladder cancer. Korean J Hepatobiliary Pancreat Surg 2012;16:59-64. [PMID: 26388908 DOI: 10.14701/kjhbps.2012.16.2.59] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
19 Ouyang B, Pan N, Zhang H, Xing C, Ji W. miR‑146b‑5p inhibits tumorigenesis and metastasis of gallbladder cancer by targeting Toll‑like receptor 4 via the nuclear factor‑κB pathway. Oncol Rep 2021;45:15. [PMID: 33649824 DOI: 10.3892/or.2021.7966] [Reference Citation Analysis]
20 Kornprat P, Rehak P, Rüschoff J, Langner C. Expression of IGF-I, IGF-II, and IGF-IR in gallbladder carcinoma. A systematic analysis including primary and corresponding metastatic tumours. J Clin Pathol 2006;59:202-6. [PMID: 16443739 DOI: 10.1136/jcp.2005.028480] [Cited by in Crossref: 32] [Cited by in F6Publishing: 74] [Article Influence: 2.0] [Reference Citation Analysis]
21 Li JY, Quan ZW, Zhang Q, Liu JW. The synergistic inhibitory effect of somatostatin-doxorubicin co-treatment on gallbladder carcinoma. BMC Cancer. 2007;7:125. [PMID: 17617924 DOI: 10.1186/1471-2407-7-125] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
22 Sharma A, Sharma KL, Gupta A, Yadav A, Kumar A. Gallbladder cancer epidemiology, pathogenesis and molecular genetics: Recent update. World J Gastroenterol 2017; 23(22): 3978-3998 [PMID: 28652652 DOI: 10.3748/wjg.v23.i22.3978] [Cited by in CrossRef: 159] [Cited by in F6Publishing: 134] [Article Influence: 31.8] [Reference Citation Analysis]
23 Romero-González RJ, Garza-Flores A, Martínez-PérezMaldonado L, Díaz-Elizondo JA, Muñiz-Eguía JJ, Barbosa-Quintana A. Gallbladder selection for histopathological analysis based on a simple method: a prospective comparative study. Ann R Coll Surg Engl 2012;94:159-64. [PMID: 22507718 DOI: 10.1308/003588412X13171221589810] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
24 Lee A, Forse CL, Walsh C, Bertens K, Balaa F. Diagnostic and surgical dilemma of cholecystitis that mimics cancer - A case report of xanthogranulomatous cholecystitis. Int J Surg Case Rep 2020;77:459-62. [PMID: 33395825 DOI: 10.1016/j.ijscr.2020.11.030] [Reference Citation Analysis]
25 Ortiz J, Reich D, Joon HB, Martinez O, Manzarbeitia C. Six year disease free survival after liver transplantation in a patient with T3 gallbladder carcinoma: case presentation and review of the literature. World J Surg Oncol 2006;4:45. [PMID: 16842623 DOI: 10.1186/1477-7819-4-45] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
26 Oikarinen H. Diagnostic imaging of carcinomas of the gallbladder and the bile ducts. Acta Radiol 2006;47:345-58. [PMID: 16739693 DOI: 10.1080/02841850600580317] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
27 Dwivedi AND, Jain S, Dixit R. Gall bladder carcinoma: Aggressive malignancy with protean loco-regional and distant spread. World J Clin Cases 2015; 3(3): 231-244 [PMID: 25789296 DOI: 10.12998/wjcc.v3.i3.231] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 35] [Article Influence: 5.6] [Reference Citation Analysis]
28 Guo R, Qin Y, Shi P, Xie J, Chou M, Chen Y. IL-1β promotes proliferation and migration of gallbladder cancer cells via Twist activation. Oncol Lett 2016;12:4749-55. [PMID: 28105184 DOI: 10.3892/ol.2016.5254] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
29 Takada N, Sugano H, Shirai Y, Saito N, Hamura R, Taniai T, Uwagawa T, Yanaga K, Ikegami T, Ohashi T, Eto K. Nafamostat mesilate, a nuclear factor kappa B inhibitor, enhances the antitumor action of radiotherapy on gallbladder cancer cells. PLoS One 2021;16:e0257019. [PMID: 34473771 DOI: 10.1371/journal.pone.0257019] [Reference Citation Analysis]
30 Tantia O, Jain M, Khanna S, Sen B. Incidental carcinoma gall bladder during laparoscopic cholecystectomy for symptomatic gall stone disease. Surg Endosc 2009;23:2041-6. [PMID: 18443860 DOI: 10.1007/s00464-008-9950-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
31 Batmunkh E, Shimada M, Morine Y, Imura S, Kanemura H, Arakawa Y, Hanaoka J, Kanamoto M, Sugimoto K, Nishi M. Expression of hypoxia-inducible factor-1 alpha (HIF-1alpha) in patients with the gallbladder carcinoma. Int J Clin Oncol. 2010;15:59-64. [PMID: 20082206 DOI: 10.1007/s10147-009-0011-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
32 Gautam A, Pandey A, Masood S, Chauhan S, Choudhary D, Kumar S, Madhawan S, Jha S, Saini V. Incidental Gallbladder Carcinoma in Gallbladder Polyps: Challenges of Gallbladder Malignancy for an Endemic Population. Malays J Med Sci 2021;28:27-34. [PMID: 33679217 DOI: 10.21315/mjms2021.28.1.4] [Reference Citation Analysis]
33 Wang J, Dou KF. Expression of hPTTG1 and bFGF in gallbladder carcinoma tissue and their correlation with angiogenesis. Shijie Huaren Xiaohua Zazhi 2004; 12(3): 680-684 [DOI: 10.11569/wcjd.v12.i3.680] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
34 Jiao K, Jiang W, Zhao C, Su D, Zhang H. Bmi-1 in gallbladder carcinoma: Clinicopathology and mechanism of regulation of human gallbladder carcinoma proliferation. Oncol Lett 2019;18:1365-71. [PMID: 31423199 DOI: 10.3892/ol.2019.10408] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
35 Maynard H, Stadler ZK, Berger MF, Solit DB, Ly M, Lowery MA, Mandelker D, Zhang L, Jordan E, El Dika I, Kemel Y, Ladanyi M, Robson ME, O'Reilly EM, Abou-Alfa GK. Germline alterations in patients with biliary tract cancers: A spectrum of significant and previously underappreciated findings. Cancer 2020;126:1995-2002. [PMID: 32012241 DOI: 10.1002/cncr.32740] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
36 Zheng X, Gao L, Wang BT, Shen P, Yuan XF, Zhang LQ, Yang L, Zhang DP, Zhang Q, Wang XM. Overexpression of EIF5A2 is associated with poor survival and aggressive tumor biology in gallbladder cancer. Histol Histopathol 2020;35:579-87. [PMID: 31745968 DOI: 10.14670/HH-18-186] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
37 Rathanaswamy S, Misra S, Kumar V, Chintamani J, Agarwal A, Gupta S. Incidentally detected gallbladder cancer- the controversies and algorithmic approach to management. Indian J Surg. 2012;74:248-254. [PMID: 23730052 DOI: 10.1007/s12262-012-0592-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
38 Imperatori M, D'Onofrio L, Marrucci E, Pantano F, Zoccoli A, Tonini G. Neoadjuvant treatment of biliary tract cancer: state-of-the-art and new perspectives. Hepat Oncol 2016;3:93-9. [PMID: 30191029 DOI: 10.2217/hep.15.43] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
39 Engineer R, Patkar S, Lewis SC, Sharma AD, Shetty N, Ostwal V, Ramaswamy A, Chopra S, Agrawal A, Patil P, Mehta S, Goel M. A phase III randomised clinical trial of perioperative therapy (neoadjuvant chemotherapy versus chemoradiotherapy) in locally advanced gallbladder cancers (POLCAGB): study protocol. BMJ Open 2019;9:e028147. [PMID: 31253621 DOI: 10.1136/bmjopen-2018-028147] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
40 Kim SM, Oh SJ, Hur B. Expression of MUC1 and MUC4 in gallbladder adenocarcinoma. Korean J Pathol 2012;46:429-35. [PMID: 23136569 DOI: 10.4132/KoreanJPathol.2012.46.5.429] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
41 Goetze TO, Paolucci V. Prognosis of incidental gallbladder carcinoma is not influenced by the primary access technique: analysis of 837 incidental gallbladder carcinomas in the German Registry. Surg Endosc 2013;27:2821-8. [PMID: 23404149 DOI: 10.1007/s00464-013-2819-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
42 Li H, Hu Y, Jin Y, Zhu Y, Hao Y, Liu F, Yang Y, Li G, Song X, Ye Y, Xiang S, Gao Y, Zhu J, Zhang Y, Jiang L, Huang W, Zhu J, Wu X, Liu Y. Long noncoding RNA lncGALM increases risk of liver metastasis in gallbladder cancer through facilitating N-cadherin and IL-1β-dependent liver arrest and tumor extravasation. Clin Transl Med 2020;10:e201. [PMID: 33252861 DOI: 10.1002/ctm2.201] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
43 Zheng Y, Tu X, Zhao P, Jiang W, Liu L, Tong Z, Zhang H, Yan C, Fang W, Wang W. A randomised phase II study of second-line XELIRI regimen versus irinotecan monotherapy in advanced biliary tract cancer patients progressed on gemcitabine and cisplatin. Br J Cancer 2018;119:291-5. [PMID: 29955136 DOI: 10.1038/s41416-018-0138-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
44 Zhang X, Kong Z, Xu X, Yun X, Chao J, Ding D, Li T, Gao Y, Guan N, Zhu C, Qin X. ARRB1 Drives Gallbladder Cancer Progression by Facilitating TAK1/MAPK Signaling Activation. J Cancer 2021;12:1926-35. [PMID: 33753990 DOI: 10.7150/jca.53325] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Chen C, Rui Z, Yuhan W, Yongjie Z, Yinghe Q, Ning Y, Tianqiang S, Jianying L, Jiangtao L, Xianhai M, Shengping L, Shubin S, Zhiqiang C, Zhaohui T, Zhimin G. Optimal Lymph Node Staging System in Evaluating Prognosis of Gallbladder Carcinoma: A Multi-institutional Study. Ann Surg Oncol 2021. [PMID: 34532819 DOI: 10.1245/s10434-021-10749-w] [Reference Citation Analysis]
46 Wan X, Zhang H, Chen C, Yang X, Wang A, Zhu C, Fu L, Miao R, He L, Yang H, Zhao H, Sang X. Clinicopathological features of gallbladder papillary adenocarcinoma. Medicine (Baltimore). 2014;93:e131. [PMID: 25501049 DOI: 10.1097/md.0000000000000131] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
47 Yoo J, Choi JY, Lee KT, Heo JS, Park SB, Moon SH, Choe YS, Lee KH, Kim BT. Prognostic Significance of Volume-based Metabolic Parameters by (18)F-FDG PET/CT in Gallbladder Carcinoma. Nucl Med Mol Imaging 2012;46:201-6. [PMID: 24900061 DOI: 10.1007/s13139-012-0147-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
48 Daldoul S, Moussi A. Gallbladder Adenosquamous Carcinoma Associated with Biliopancreatic Maljunction and Cystic Metastases of the Liver Miming Abscess. Indian J Surg 2015;77:1387-8. [PMID: 27011570 DOI: 10.1007/s12262-013-1012-3] [Reference Citation Analysis]
49 Huang CS, Xu QC, Dai C, Wang L, Tien YC, Li F, Su Q, Huang XT, Wu J, Zhao W, Yin XY. Nanomaterial-Facilitated Cyclin-Dependent Kinase 7 Inhibition Suppresses Gallbladder Cancer Progression via Targeting Transcriptional Addiction. ACS Nano 2021;15:14744-55. [PMID: 34405985 DOI: 10.1021/acsnano.1c04570] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
50 Zemour J, Marty M, Lapuyade B, Collet D, Chiche L. Vésicules tumorales et pseudo-tumorales : diagnostic et conduite à tenir. Journal de Chirurgie Viscérale 2014;151:295-306. [DOI: 10.1016/j.jchirv.2014.03.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
51 Das AV, Pillai RM. Implications of miR cluster 143/145 as universal anti-oncomiRs and their dysregulation during tumorigenesis. Cancer Cell Int 2015;15:92. [PMID: 26425114 DOI: 10.1186/s12935-015-0247-4] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 4.9] [Reference Citation Analysis]
52 Nengwen K, Yong Z. Aggressive Surgical Management of Gallbladder Cancer: Long-Term Results From a Retrospective Study of 315 Chinese Patients. International Surgery 2021;105:346-52. [DOI: 10.9738/intsurg-d-15-00328.1] [Reference Citation Analysis]
53 Ren T, Li Y, Zhang X, Geng Y, Shao Z, Li M, Wu X, Wang XA, Liu F, Wu W, Shu Y, Bao R, Gong W, Dong P, Dang X, Liu C, Liu C, Sun B, Liu J, Wang L, Hong D, Qin R, Jiang X, Zhang X, Xu J, Jia J, Yang B, Li B, Dai C, Cao J, Cao H, Tao F, Zhang Z, Wang Y, Jin H, Cai H, Fei Z, Gu J, Han W, Feng X, Fang L, Zheng L, Zhu C, Wang K, Zhang X, Li X, Jin C, Qian Y, Cui Y, Xu Y, Wang X, Liu H, Hua Y, Liu C, Hao J, Wang C, Li Q, Li X, Liu J, Li M, Qiu Y, Wu B, Zheng J, Chen X, Zhu H, Hua K, Yan M, Wang P, Zang H, Ma X, Hong J, Liu Y. Protocol for a gallbladder cancer registry study in China: the Chinese Research Group of Gallbladder Cancer (CRGGC) study. BMJ Open 2021;11:e038634. [PMID: 33593763 DOI: 10.1136/bmjopen-2020-038634] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
54 Rustagi T, Dasanu CA. Risk factors for gallbladder cancer and cholangiocarcinoma: similarities, differences and updates. J Gastrointest Cancer 2012;43:137-47. [PMID: 21597894 DOI: 10.1007/s12029-011-9284-y] [Cited by in Crossref: 42] [Cited by in F6Publishing: 30] [Article Influence: 4.2] [Reference Citation Analysis]
55 Reid KM, Ramos-De la Medina A, Donohue JH. Diagnosis and surgical management of gallbladder cancer: a review. J Gastrointest Surg. 2007;11:671-681. [PMID: 17468929 DOI: 10.1007/s11605-006-0075-x] [Cited by in Crossref: 142] [Cited by in F6Publishing: 130] [Article Influence: 9.5] [Reference Citation Analysis]
56 Yang F, Tang Z, Duan A, Yi B, Shen N, Bo Z, Yin L, Zhu B, Qiu Y, Li J. Long Noncoding RNA NEAT1 Upregulates Survivin and Facilitates Gallbladder Cancer Progression by Sponging microRNA-335. Onco Targets Ther 2020;13:2357-67. [PMID: 32256086 DOI: 10.2147/OTT.S236350] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
57 Chen L, Xu L, Shen L, Luo R, Jiang D, Wang Y, Li W, Hou Y. HER2 Positivity Is Affected by the Papillary Structure and Has a Bidirectional Prognostic Value for Gallbladder Carcinoma. Front Genet 2022;12:831318. [DOI: 10.3389/fgene.2021.831318] [Reference Citation Analysis]
58 Xie Y, Zhang L, Zhan L. Can we assess the advancements of gallbladder cancer using red blood cell distribution width? Medicine (Baltimore) 2019;98:e18364. [PMID: 31860995 DOI: 10.1097/MD.0000000000018364] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
59 Fan YZ, Fu JY, Zhao ZM, Chen CQ. Effect of norcantharidin on proliferation and invasion of human gallbladder carcinoma GBC-SD cells. World J Gastroenterol 2005; 11(16): 2431-2437 [PMID: 15832413 DOI: 10.3748/wjg.v11.i16.2431] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
60 Sharma KL, Yadav A, Gupta A, Tulsayan S, Kumar V, Misra S, Kumar A, Mittal B. Association of genetic variants of cancer stem cell gene CD44 haplotypes with gallbladder cancer susceptibility in North Indian population. Tumour Biol. 2014;35:2583-2589. [PMID: 24186075 DOI: 10.1007/s13277-013-1340-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
61 Zaidi MY, Abou-Alfa GK, Ethun CG, Shrikhande SV, Goel M, Nervi B, Primrose J, Valle JW, Maithel SK. Evaluation and management of incidental gallbladder cancer. Chin Clin Oncol 2019;8:37. [PMID: 31431030 DOI: 10.21037/cco.2019.07.01] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
62 Du X, Wang S, Lu J, Wang Q, Song N, Yang T, Dong R, Zang L, Yang Y, Wu T, Wang C. Clinical value of Tiam1-Rac1 signaling in primary gallbladder carcinoma. Med Oncol 2012;29:1873-8. [PMID: 21853342 DOI: 10.1007/s12032-011-0046-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
63 Miyakawa S, Ishihara S, Takada T, Miyazaki M, Tsukada K, Nagino M, Kondo S, Furuse J, Saito H, Tsuyuguchi T. Flowcharts for the management of biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg. 2008;15:7-14. [PMID: 18274839 DOI: 10.1007/s00534-007-1275-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
64 Saluja SS, Nekarakanti PK, Mishra PK, Srivastava A, Singh K. Prospective Randomized Controlled Trial Comparing Adjuvant Chemotherapy vs. No Chemotherapy for Patients with Carcinoma of Gallbladder Undergoing Curative Resection. J Gastrointest Surg 2021. [PMID: 34545545 DOI: 10.1007/s11605-021-05143-6] [Reference Citation Analysis]
65 Sharma KL, Umar M, Pandey M, Misra S, Kumar A, Kumar V, Mittal B. Association of potentially functional genetic variants of PLCE1 with gallbladder cancer susceptibility in north Indian population. J Gastrointest Cancer. 2013;44:436-443. [PMID: 23975622 DOI: 10.1007/s12029-013-9537-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
66 Higo H, Suzaki N, Nagata T, Togami T, Ohara N, Marukawa M. Pulmonary lymphangitic carcinomatosis from gallbladder cancer mimicking diffuse alveolar haemorrhage. Respirol Case Rep 2020;8:e00540. [PMID: 32148839 DOI: 10.1002/rcr2.540] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
67 Zhang C, Zhang W, Mu D, Shi X, Zhao L. A clear cell adenocarcinoma of the gallbladder with hepatoid differentiation: case report and review of literature. Onco Targets Ther 2016;9:5797-802. [PMID: 27703378 DOI: 10.2147/OTT.S103291] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
68 Li X, Teng S, Zhang Y, Zhang W, Zhang X, Xu K, Yao H, Yao J, Wang H, Liang X, Hu Z. TROP2 promotes proliferation, migration and metastasis of gallbladder cancer cells by regulating PI3K/AKT pathway and inducing EMT. Oncotarget 2017;8:47052-63. [PMID: 28423362 DOI: 10.18632/oncotarget.16789] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 7.8] [Reference Citation Analysis]
69 Gwark SC, Hwang S, Kim KH, Lee YJ, Park KM, Ahn CS, Moon DB, Ha TY, Song GW, Jung DH, Park GC, Lee SG. Extent of resection for T2N0 gallbladder carcinoma regarding concurrent extrahepatic bile duct resection. Korean J Hepatobiliary Pancreat Surg 2012;16:142-6. [PMID: 26388925 DOI: 10.14701/kjhbps.2012.16.4.142] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
70 de Bitter TJJ, Kroeze LI, de Reuver PR, van Vliet S, Vink-Börger E, von Rhein D, Jansen EAM, Nagtegaal ID, Ligtenberg MJL, van der Post RS. Unraveling Neuroendocrine Gallbladder Cancer: Comprehensive Clinicopathologic and Molecular Characterization. JCO Precis Oncol 2021;5:PO. [PMID: 34036234 DOI: 10.1200/PO.20.00487] [Reference Citation Analysis]
71 Akatsu T, Yoshida M, Kubota T, Shimazu M, Ueda M, Otani Y, Wakabayashi G, Aiura K, Tanabe M, Furukawa T, Saikawa Y, Kawachi S, Akatsu Y, Kumai K, Kitajima M. Gallstone disease after extended (D2) lymph node dissection for gastric cancer. World J Surg 2005;29:182-6. [PMID: 15654665 DOI: 10.1007/s00268-004-7482-5] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
72 Shen CM, Niu GC, Cui W, Li HK, Li Q. The improvement of surgical treatment for patients with gallbladder cancer: analysis of 208 consecutive cases over the past decade. J Gastrointest Surg 2012;16:2239-46. [PMID: 23065499 DOI: 10.1007/s11605-012-2042-z] [Reference Citation Analysis]
73 Sharma KL, Misra S, Kumar A, Mittal B. Association of liver X receptors (LXRs) genetic variants to gallbladder cancer susceptibility. Tumour Biol. 2013;34:3959-3966. [PMID: 23838803 DOI: 10.1007/s13277-013-0984-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
74 Chan TF, Wu CH, Chiu HF, Yang CY. Parity and risk of death from gallbladder cancer among a cohort of premenopausal parous women in Taiwan. Int J Environ Res Public Health 2015;12:1864-73. [PMID: 25664696 DOI: 10.3390/ijerph120201864] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
75 Hong Z, Chen Y, Chen J, Chen H, Xu Y, Zhu X, Zhuo S, Shi Z, Chen J. Optical diagnosis of gallbladder cancers via two-photon excited fluorescence imaging of unstained histological sections. Lasers Med Sci 2015;30:225-33. [PMID: 25199550 DOI: 10.1007/s10103-014-1652-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
76 Yu J, Tang Z, Gong W, Zhang M, Quan Z. Isolation and identification of tumor-initiating cell properties in human gallbladder cancer cell lines using the marker cluster of differentiation 133. Oncol Lett 2017;14:7111-20. [PMID: 29344142 DOI: 10.3892/ol.2017.7159] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
77 Nagahashi M, Ajioka Y, Lang I, Szentirmay Z, Kasler M, Nakadaira H, Yokoyama N, Watanabe G, Nishikura K, Wakai T, Shirai Y, Hatakeyama K, Yamamoto M. Genetic changes of p53, K-ras, and microsatellite instability in gallbladder carcinoma in high-incidence areas of Japan and Hungary. World J Gastroenterol 2008; 14(1): 70-75 [PMID: 18176964 DOI: 10.3748/wjg.14.70] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 38] [Article Influence: 2.8] [Reference Citation Analysis]
78 Xu WY, Zhang HH, Xiong JP, Yang XB, Bai Y, Lin JZ, Long JY, Zheng YC, Zhao HT, Sang XT. Prognostic significance of the fibrinogen-to-albumin ratio in gallbladder cancer patients. World J Gastroenterol 2018; 24(29): 3281-3292 [PMID: 30090008 DOI: 10.3748/wjg.v24.i29.3281] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 34] [Article Influence: 8.8] [Reference Citation Analysis]
79 Odutola MK, Olukomogbon T, Igbinoba F, Otu TI, Ezeome E, Hassan R, Jedy-Agba E, Adebamowo SN. Cancers Attributable to Overweight and Obesity From 2012 to 2014 in Nigeria: A Population-Based Cancer Registry Study. Front Oncol 2019;9:460. [PMID: 31245287 DOI: 10.3389/fonc.2019.00460] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
80 Chen HD, Li F, Chen S, Zhong ZH, Gao PF, Gao WZ. METTL3-mediated N6-methyladenosine modification of DUSP5 mRNA promotes gallbladder-cancer progression. Cancer Gene Ther 2021. [PMID: 34799724 DOI: 10.1038/s41417-021-00406-5] [Reference Citation Analysis]
81 Tan W, Gao M, Liu N, Zhang G, Xu T, Cui W. Body Mass Index and Risk of Gallbladder Cancer: Systematic Review and Meta-Analysis of Observational Studies. Nutrients 2015;7:8321-34. [PMID: 26426043 DOI: 10.3390/nu7105387] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
82 Park JK, Yoon YB, Kim YT, Ryu JK, Yoon WJ, Lee SH, Yu SJ, Kang HY, Lee JY, Park MJ. Management strategies for gallbladder polyps: is it possible to predict malignant gallbladder polyps? Gut Liver 2008;2:88-94. [PMID: 20485616 DOI: 10.5009/gnl.2008.2.2.88] [Cited by in Crossref: 58] [Cited by in F6Publishing: 47] [Article Influence: 4.1] [Reference Citation Analysis]
83 Yang Z, Ren T, Liu S, Cai C, Gong W, Shu Y. Preoperative serum fibrinogen as a valuable predictor in the nomogram predicting overall survival of postoperative patients with gallbladder cancer. J Gastrointest Oncol 2021;12:1661-72. [PMID: 34532118 DOI: 10.21037/jgo-21-357] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
84 Razumilava N, Gores GJ, Lindor KD. Cancer surveillance in patients with primary sclerosing cholangitis. Hepatology 2011;54:1842-52. [PMID: 21793028 DOI: 10.1002/hep.24570] [Cited by in Crossref: 191] [Cited by in F6Publishing: 165] [Article Influence: 17.4] [Reference Citation Analysis]
85 Letelier P, Riquelme I, Hernández AH, Guzmán N, Farías JG, Roa JC. Circulating MicroRNAs as Biomarkers in Biliary Tract Cancers. Int J Mol Sci 2016;17:E791. [PMID: 27223281 DOI: 10.3390/ijms17050791] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
86 Gao Y, Wang Z, Zhu Y, Zhu Q, Yang Y, Jin Y, Zhang F, Jiang L, Ye Y, Li H, Zhang Y, Liang H, Xiang S, Miao H, Liu Y, Hao Y. NOP2/Sun RNA methyltransferase 2 promotes tumor progression via its interacting partner RPL6 in gallbladder carcinoma. Cancer Sci 2019;110:3510-9. [PMID: 31487418 DOI: 10.1111/cas.14190] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
87 Agarwal A, Pareek P, Misra S. Carcinoma Gallbladder- an Indian Problem. Indian J Surg Oncol 2016;7:2-3. [PMID: 27279722 DOI: 10.1007/s13193-016-0507-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
88 Tadokoro H, Shigihara T, Ikeda T, Takase M, Suyama M. Two distinct pathways of p16 gene inactivation in gallbladder cancer. World J Gastroenterol 2007; 13(47): 6396-6403 [PMID: 18081229 DOI: 10.3748/wjg.v13.i47.6396] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
89 Wakai T, Nagahashi M, Shimada Y, Prasoon P, Sakata J. Genetic analysis in the clinical management of biliary tract cancer. Ann Gastroenterol Surg 2020;4:316-23. [PMID: 32724874 DOI: 10.1002/ags3.12334] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
90 Inoue M, Hakoda K, Sawada H, Hotta R, Ohmori I, Miyamoto K, Toyota K, Sadamoto S, Takahashi T. Locally advanced gallbladder cancer treated with effective chemotherapy and subsequent curative resection: a case report. J Med Case Rep 2022;16:30. [PMID: 35039070 DOI: 10.1186/s13256-021-03248-9] [Reference Citation Analysis]
91 Li M, Chen L, Qu Y, Sui F, Yang Q, Ji M, Shi B, Chen M, Hou P. Identification of MAP kinase pathways as therapeutic targets in gallbladder carcinoma using targeted parallel sequencing. Oncotarget 2017;8:36319-30. [PMID: 28422736 DOI: 10.18632/oncotarget.16751] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
92 Saini VK, Hassan A, Singh AK, Ora M, Gambhir S. Port-Site Metastases in Incidentally Detected Carcinoma Gall Bladder: Role of 18F-FDG PET/CT and Patient Outcome. J Gastrointest Canc. [DOI: 10.1007/s12029-021-00746-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
93 Leiting JL, Murphy SJ, Bergquist JR, Hernandez MC, Ivanics T, Abdelrahman AM, Yang L, Lynch I, Smadbeck JB, Cleary SP, Nagorney DM, Torbenson MS, Graham RP, Roberts LR, Gores GJ, Smoot RL, Truty MJ. Biliary tract cancer patient-derived xenografts: Surgeon impact on individualized medicine. JHEP Rep 2020;2:100068. [PMID: 32181445 DOI: 10.1016/j.jhepr.2020.100068] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
94 Yadav A, Gupta A, Rastogi N, Agrawal S, Kumar A, Kumar V, Mittal B. Association of cancer stem cell markers genetic variants with gallbladder cancer susceptibility, prognosis, and survival. Tumour Biol. 2016;37:1835-1844. [PMID: 26318430 DOI: 10.1007/s13277-015-3929-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
95 Hu YP, Jin YP, Wu XS, Yang Y, Li YS, Li HF, Xiang SS, Song XL, Jiang L, Zhang YJ, Huang W, Chen SL, Liu FT, Chen C, Zhu Q, Chen HZ, Shao R, Liu YB. LncRNA-HGBC stabilized by HuR promotes gallbladder cancer progression by regulating miR-502-3p/SET/AKT axis. Mol Cancer 2019;18:167. [PMID: 31752906 DOI: 10.1186/s12943-019-1097-9] [Cited by in Crossref: 38] [Cited by in F6Publishing: 44] [Article Influence: 12.7] [Reference Citation Analysis]
96 Tsukada K, Takada T, Miyazaki M, Miyakawa S, Nagino M, Kondo S, Furuse J, Saito H, Tsuyuguchi T, Kimura F. Diagnosis of biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg. 2008;15:31-40. [PMID: 18274842 DOI: 10.1007/s00534-007-1278-6] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
97 Kleinlützum D, Plesker R. A case of gallstones in an African green monkey (Chlorocebus aethiops). Primate Biol 2017;4:33-7. [PMID: 32110690 DOI: 10.5194/pb-4-33-2017] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
98 Zhang Y, You WH, Li X, Wang P, Sha B, Liang Y, Qiu J, Zhou J, Hu H, Lu L. Single-cell RNA-seq reveals transcriptional landscape and intratumor heterogenicity in gallbladder cancer liver metastasis microenvironment. Ann Transl Med 2021;9:889. [PMID: 34164523 DOI: 10.21037/atm-21-2227] [Reference Citation Analysis]
99 Chin KF, Mohammad AA, Khoo YY, Krishnasamy T. The impact of routine histopathological examination on cholecystectomy specimens from an Asian demographic. Ann R Coll Surg Engl 2012;94:165-9. [PMID: 22507719 DOI: 10.1308/003588412X13171221501708] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
100 Hou JZ, Zeng ZC, Sun J, Ji Y. Conformal radiotherapy for squamous cell carcinoma of gallbladder: a case report. Case Rep Med 2010;2010:645172. [PMID: 20339506 DOI: 10.1155/2010/645172] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
101 Kanthan R, Senger JL, Ahmed S, Kanthan SC. Gallbladder Cancer in the 21st Century. J Oncol. 2015;2015:967472. [PMID: 26421012 DOI: 10.1155/2015/967472] [Cited by in Crossref: 106] [Cited by in F6Publishing: 111] [Article Influence: 15.1] [Reference Citation Analysis]
102 Kang CM, Choi GH, Park SH, Kim KS, Choi JS, Lee WJ, Kim BR. Laparoscopic cholecystectomy only could be an appropriate treatment for selected clinical R0 gallbladder carcinoma. Surg Endosc 2007;21:1582-7. [DOI: 10.1007/s00464-006-9133-4] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
103 Xu Q, Wang L, Tong T, Huang X, Huang C, Li F, Su Q, Tien Y, Wu J, Zhao W, Yin X. Efficient delivery of BRD4 inhibitor by glutathione-sensitive nanoparticle to suppress gallbladder cancer through inhibiting NF-κB signaling. Applied Materials Today 2020;21:100849. [DOI: 10.1016/j.apmt.2020.100849] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
104 Srivastava A, Sharma KL, Srivastava N, Misra S, Mittal B. Significant role of estrogen and progesterone receptor sequence variants in gallbladder cancer predisposition: a multi-analytical strategy. PLoS One. 2012;7:e40162. [PMID: 22808109 DOI: 10.1371/journal.pone.0040162] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
105 Gupta S, Garg S, Kumar V, Chaturvedi A, Misra S, Akhtar N, Rajan S, Kaur J, Lakshmanan M, Jain K. Study of tumor transglutaminase 2 expression in gallbladder cancer - Is it a novel predictor of survival? Ann Hepatobiliary Pancreat Surg 2020;24:460-8. [PMID: 33234749 DOI: 10.14701/ahbps.2020.24.4.460] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
106 Wu K, Liao M, Liu B, Deng Z. ADAM-17 over-expression in gallbladder carcinoma correlates with poor prognosis of patients. Med Oncol. 2011;28:475-480. [PMID: 20300969 DOI: 10.1007/s12032-010-9481-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
107 Kagohara LT, Schussel JL, Subbannayya T, Sahasrabuddhe N, Lebron C, Brait M, Maldonado L, Valle BL, Pirini F, Jahuira M. Global and gene-specific DNA methylation pattern discriminates cholecystitis from gallbladder cancer patients in Chile. Future Oncol. 2015;11:233-249. [PMID: 25066711 DOI: 10.2217/fon.14.165] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
108 Gupta S, Prakash P, Kumar V, Chaturvedi A, Misra S, Akhtar N, Rajan S, Agarwal P, Smith LM, Are C. Radical surgery for de novo gallbladder carcinoma-Single-center analysis of prognostic factors and survival outcomes from an endemic region. J Surg Oncol 2021. [PMID: 34894351 DOI: 10.1002/jso.26766] [Reference Citation Analysis]
109 Singla V, Agarwal R, Anikhindi SA, Puri P, Kumar M, Ranjan P, Kumar A, Sharma P, Bansal N, Bakshi P, Verma K, Arora A. Role of EUS-FNA for gallbladder mass lesions with biliary obstruction: a large single-center experience. Endosc Int Open 2019;7:E1403-9. [PMID: 31673611 DOI: 10.1055/a-0982-2862] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
110 Xu LN, Zou SQ. A clinicopathological analysis in unsuspected gallbladder carcinoma: A report of 23 cases. World J Gastroenterol 2007; 13(12): 1857-1861 [PMID: 17465481 DOI: 10.3748/wjg.v13.i12.1857] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
111 Nagahashi M, Shirai Y, Wakai T, Sakata J, Ajioka Y, Hatakeyama K. Perimuscular connective tissue contains more and larger lymphatic vessels than the shallower layers in human gallbladders. World J Gastroenterol 2007; 13(33): 4480-4483 [PMID: 17724804 DOI: 10.3748/wjg.v13.i33.4480] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
112 Tao J, Xu XS, Song YZ, Qu K, Wu QF, Wang RT, Meng FD, Wei JC, Dong SB, Zhang YL, Tai MH, Dong YF, Wang L, Liu C. Down-regulation of FoxM1 inhibits viability and invasion of gallbladder carcinoma cells, partially dependent on inducement of cellular senescence. World J Gastroenterol 2014; 20(28): 9497-9505 [PMID: 25071344 DOI: 10.3748/wjg.v20.i28.9497] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
113 Halder S, Kundu S, Chakraborty J, Chakrabarti S. Significance of HER2 and Ki-67 in Preneoplastic Lesions and Carcinoma of Gallbladder. J Gastrointest Cancer 2019;50:848-54. [PMID: 30155833 DOI: 10.1007/s12029-018-0162-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
114 Zhao DY, Lim KH. Current biologics for treatment of biliary tract cancers. J Gastrointest Oncol 2017;8:430-40. [PMID: 28736630 DOI: 10.21037/jgo.2017.05.04] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 5.4] [Reference Citation Analysis]
115 Bazan F, Sanchez J, Aguilar G, Radosevic A, Busto M, Zuccarino F, Pijuan L, Risueño N. Metastatic gallbladder adenocarcinoma with signet-ring cells: A case report. J Med Case Rep 2011;5:458. [PMID: 21917161 DOI: 10.1186/1752-1947-5-458] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
116 Chen M, Juengpanich S, Li S, Topatana W, Lu Z, Zheng Q, Cao J, Hu J, Chan E, Hou L, Chen J, Chen F, Liu Y, Jiansirisomboon S, Gu Z, Tongpeng S, Cai X. Bortezomib-Encapsulated Dual Responsive Copolymeric Nanoparticles for Gallbladder Cancer Targeted Therapy. Adv Sci (Weinh) 2022;9:e2103895. [PMID: 35068071 DOI: 10.1002/advs.202103895] [Reference Citation Analysis]
117 Larsson SC, Wolk A. Obesity and the risk of gallbladder cancer: a meta-analysis. Br J Cancer 2007;96:1457-61. [PMID: 17375043 DOI: 10.1038/sj.bjc.6603703] [Cited by in Crossref: 97] [Cited by in F6Publishing: 91] [Article Influence: 6.5] [Reference Citation Analysis]
118 Madhawi R, Pandey A, Raj S, Mandal M, Devi S, Sinha PK, Singh RK. Geographical pattern of carcinoma gallbladder in Bihar and its association with river Ganges and arsenic levels: Retrospective individual consecutive patient data from Regional Cancer Centre. South Asian J Cancer 2018;7:167-70. [PMID: 30112331 DOI: 10.4103/sajc.sajc_37_18] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
119 Zhou Y, Lizaso A, Mao X, Yang N, Zhang Y. Novel AMBRA1-ALK fusion identified by next-generation sequencing in advanced gallbladder cancer responds to crizotinib: a case report. Ann Transl Med 2020;8:1099. [PMID: 33145318 DOI: 10.21037/atm-20-1007] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
120 Saritas AG, Gul MO, Teke Z, Ulku A, Rencuzogullari A, Aydin I, Akcam AT. Xanthogranulomatous cholecystitis: a rare gallbladder pathology from a single-center perspective. Ann Surg Treat Res 2020;99:230-7. [PMID: 33029482 DOI: 10.4174/astr.2020.99.4.230] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
121 Zhang XZ, Tu JJ, Chen W, Ma T, Bai XL, Liang TB. Gallbladder cancer with tumor thrombus in the portal vein: A case report. Medicine (Baltimore) 2018;97:e0271. [PMID: 29668579 DOI: 10.1097/MD.0000000000010271] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
122 Sameer G, Naseem A, Vijay K, Sanjeev M, Jaswant J, Vadakkanchery AS. Skeletal metastasis in gallbladder cancer from a high-volume tertiary care center of north India: a series of rare occurrence. J Gastrointest Cancer 2015;46:36-41. [PMID: 25432582 DOI: 10.1007/s12029-014-9666-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
123 Ozer M, Goksu SY, Sanford NN, Porembka M, Khurshid H, Ahn C, Maxwell MC, Beg MS, Kazmi SM. A Propensity Score Analysis of Chemotherapy Use in Patients With Resectable Gallbladder Cancer. JAMA Netw Open 2022;5:e2146912. [PMID: 35171262 DOI: 10.1001/jamanetworkopen.2021.46912] [Reference Citation Analysis]
124 Fan DX, Xu RW, Li YC, Zhao BQ, Sun MY. Impact of the number of examined lymph nodes on outcomes in patients with lymph node-negative gallbladder carcinoma. World J Gastroenterol 2018; 24(26): 2886-2892 [PMID: 30018483 DOI: 10.3748/wjg.v24.i26.2886] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
125 Huang J, Yang H, Wang M, Zhao X, Shao S, Zhang F, Que R, Hu Q, Liang T. Gallbladder Adenosquamous Cancer with Situs Inversus Totalis: A Case Report and Literature Review. Onco Targets Ther 2021;14:4299-304. [PMID: 34349522 DOI: 10.2147/OTT.S319030] [Reference Citation Analysis]
126 Kuzuu K, Misawa N, Ashikari K, Kessoku T, Kato S, Hosono K, Yoneda M, Nonaka T, Matsushima S, Komatsu T, Nakajima A, Higurashi T. Gastrointestinal Cancer Stage at Diagnosis Before and During the COVID-19 Pandemic in Japan. JAMA Netw Open 2021;4:e2126334. [PMID: 34546368 DOI: 10.1001/jamanetworkopen.2021.26334] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
127 Wang Y, Imran A, Shami A, Chaudhary AA, Khan S. Decipher the Helicobacter pylori Protein Targeting in the Nucleus of Host Cell and their Implications in Gallbladder Cancer: An insilico approach. J Cancer 2021;12:7214-22. [PMID: 34729122 DOI: 10.7150/jca.63517] [Reference Citation Analysis]
128 Li J, Wu T, Lu J, Cao Y, Song N, Yang T, Dong R, Yang Y, Zang L, Du X. Immunohistochemical evidence of the prognostic value of hedgehog pathway components in primary gallbladder carcinoma. Surg Today. 2012;42:770-775. [PMID: 22407314 DOI: 10.1007/s00595-012-0157-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
129 Lin Z, Yang S, Zhou Y, Hou Z, Li L, Meng M, Ge C, Zeng B, Lai J, Gao H, Zhao Y, Xie Y, He S, Tang W, Li R, Tan J, Wang W. OLFM4 depletion sensitizes gallbladder cancer cells to cisplatin through the ARL6IP1/caspase-3 axis. Transl Oncol 2022;16:101331. [PMID: 34974280 DOI: 10.1016/j.tranon.2021.101331] [Reference Citation Analysis]
130 Kai K, Aishima S, Miyazaki K. Gallbladder cancer: Clinical and pathological approach. World J Clin Cases 2014; 2(10): 515-521 [PMID: 25325061 DOI: 10.12998/wjcc.v2.i10.515] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
131 Mentella MC, Scaldaferri F, Ricci C, Gasbarrini A, Miggiano GAD. Cancer and Mediterranean Diet: A Review. Nutrients 2019;11:E2059. [PMID: 31480794 DOI: 10.3390/nu11092059] [Cited by in Crossref: 60] [Cited by in F6Publishing: 47] [Article Influence: 20.0] [Reference Citation Analysis]
132 Sahasrabuddhe NA, Barbhuiya MA, Bhunia S, Subbannayya T, Gowda H, Advani J, Shrivastav BR, Navani S, Leal P, Roa JC, Chaerkady R, Gupta S, Chatterjee A, Pandey A, Tiwari PK. Identification of prosaposin and transgelin as potential biomarkers for gallbladder cancer using quantitative proteomics. Biochem Biophys Res Commun 2014;446:863-9. [PMID: 24657443 DOI: 10.1016/j.bbrc.2014.03.017] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
133 Chen C, Wang L, Zhang R, Li Q, Zhao YL, Zhang GJ, Li WZ, Geng ZM. Who benefits from R0 resection? A single-center analysis of patients with stage Ⅳ gallbladder cancer. Chronic Dis Transl Med 2019;5:188-96. [PMID: 31891130 DOI: 10.1016/j.cdtm.2019.08.004] [Reference Citation Analysis]
134 Vishnoi M, Choudhuri G, Mittal B. Is IL-10-819C/T gene polymorphism modulating the risk of gallbladder disease in north Indian population? J Gastrointest Cancer 2007;38:46-51. [PMID: 19065724 DOI: 10.1007/s12029-008-9016-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
135 Wang J, Liu H, Shen X, Wang Y, Zhang D, Shen S, Suo T, Pan H, Ming Y, Ding K, Liu H. Long non-coding RNA expression profiles in gallbladder carcinoma identified using microarray analysis. Oncol Lett 2017;13:3508-16. [PMID: 28529578 DOI: 10.3892/ol.2017.5893] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
136 Yang DZ, He J, Zhang JC, Wang ZR. Expression of angiostatin cDNA in human gallbladder carcinoma cell line GBC-SD and its effect on endothelial proliferation and growth. World J Gastroenterol 2006; 12(17): 2762-2766 [PMID: 16718765 DOI: 10.3748/wjg.v12.i17.2762] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
137 Cox M, Patel M, Joneja U, Shaw C, O'Kane P. Focal disruption in the wall of the porcelain gallbladder: a sign of gallbladder carcinoma. Intern Emerg Med 2017;12:891-3. [PMID: 27933437 DOI: 10.1007/s11739-016-1584-6] [Reference Citation Analysis]
138 Kuipers H, de Bitter TJJ, de Boer MT, van der Post RS, Nijkamp MW, de Reuver PR, Fehrmann RSN, Hoogwater FJH. Gallbladder Cancer: Current Insights in Genetic Alterations and Their Possible Therapeutic Implications. Cancers (Basel) 2021;13:5257. [PMID: 34771420 DOI: 10.3390/cancers13215257] [Reference Citation Analysis]
139 Liu H, Zhang Y, Ai M, Wang J, Jin B, Teng Z, Wang Y, Li L. Body Mass Index Can Increase the Risk of Gallbladder Cancer: A Meta-Analysis of 14 Cohort Studies. Med Sci Monit Basic Res 2016;22:146-55. [PMID: 27899789 DOI: 10.12659/msmbr.901651] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
140 Hong H, Jiang L, Lin Y, He C, Zhu G, Du Q, Wang X, She F, Chen Y. TNF-alpha promotes lymphangiogenesis and lymphatic metastasis of gallbladder cancer through the ERK1/2/AP-1/VEGF-D pathway. BMC Cancer 2016;16:240. [PMID: 26992854 DOI: 10.1186/s12885-016-2259-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
141 Chang CK, Astrakianakis G, Thomas DB, Seixas NS, Camp JE, Ray RM, Gao DL, Wernli KJ, Li W, Fitzgibbons ED, Vaughan TL, Checkoway H. Risks of biliary tract cancer and occupational exposures among Shanghai women textile workers: a case-cohort study. Am J Ind Med 2006;49:690-8. [PMID: 16830349 DOI: 10.1002/ajim.20345] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
142 Karabulut Z, Yildirim Y, Abaci I, Ilgici D, Ozyilkan O. Signet-ring cell carcinoma of the gallbladder: a case report. Adv Ther 2008;25:520-3. [PMID: 18461291 DOI: 10.1007/s12325-008-0052-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
143 Kazmi HR, Chandra A, Baghel K, Singh A, Nigam J, Parmar D, Mahdi AA, Goel SK, Kumar S. Differential expression of cholecystokinin A receptor in gallbladder cancer in the young and elderly suggests two subsets of the same disease? Biomed Res Int 2014;2014:625695. [PMID: 25025063 DOI: 10.1155/2014/625695] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
144 Banerjee S, Chowdhury CR, Das D. Relationship of Diet and Addiction with Gall Bladder Carcinoma—a Case–Control Study at a Tertiary Health Care Centre, India. Indian J Surg Oncol. [DOI: 10.1007/s13193-021-01480-9] [Reference Citation Analysis]
145 Calomino N, Scheiterle MLPF, Fusario D, La Francesca N, Martellucci I, Marrelli D. Porcelain gallbladder and its relationship to cancer. Eur Surg 2021;53:311-6. [DOI: 10.1007/s10353-021-00710-2] [Reference Citation Analysis]
146 Cai Q, Wang S, Jin L, Weng M, Zhou D, Wang J, Tang Z, Quan Z. Long non-coding RNA GBCDRlnc1 induces chemoresistance of gallbladder cancer cells by activating autophagy. Mol Cancer. 2019;18:82. [PMID: 30953511 DOI: 10.1186/s12943-019-1016-0] [Cited by in Crossref: 50] [Cited by in F6Publishing: 63] [Article Influence: 16.7] [Reference Citation Analysis]
147 Chen M, Cao J, Bai Y, Tong C, Lin J, Jindal V, Barchi LC, Nadalin S, Yang SX, Pesce A, Panaro F, Ariche A, Kai K, Memeo R, Bekaii-Saab T, Cai X; Written on behalf of the AME Gallbladder Cancer Collaborative Group. Development and Validation of a Nomogram for Early Detection of Malignant Gallbladder Lesions. Clin Transl Gastroenterol 2019;10:e00098. [PMID: 31663905 DOI: 10.14309/ctg.0000000000000098] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
148 Zhai G, Yan K, Ji X, Xu W, Yang J, Xiong F, Su J, McNutt MA, Yang H. LAPTM4B allele *2 is a marker of poor prognosis for gallbladder carcinoma. PLoS One. 2012;7:e45290. [PMID: 22984631 DOI: 10.1371/journal.pone.0045290] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
149 Wencong M, Jinghan W, Yong Y, Jianyang A, Bin L, Qingbao C, Chen L, Xiaoqing J. FOXK1 Promotes Proliferation and Metastasis of Gallbladder Cancer by Activating AKT/mTOR Signaling Pathway. Front Oncol 2020;10:545. [PMID: 32363163 DOI: 10.3389/fonc.2020.00545] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
150 Angst E, Hiatt JR, Gloor B, Reber HA, Hines OJ. Laparoscopic surgery for cancer: a systematic review and a way forward. J Am Coll Surg 2010;211:412-23. [PMID: 20800199 DOI: 10.1016/j.jamcollsurg.2010.05.019] [Cited by in Crossref: 29] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
151 Du X, Zhao H, Zang L, Song N, Yang T, Dong R, Yin J, Wang C, Lu J. Overexpression of histone deacetylase 2 predicts unfavorable prognosis in human gallbladder carcinoma. Pathol Oncol Res 2013;19:397-403. [PMID: 23242568 DOI: 10.1007/s12253-012-9592-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
152 Williams CI, Shaffer EA. Gallstone disease: current therapeutic practice. Curr Treat Options Gastroenterol 2008;11:71-7. [PMID: 18321433 DOI: 10.1007/s11938-008-0018-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
153 Wang C, Zhao H, Lu J, Yin J, Zang L, Song N, Dong R, Wu T, Du X. Clinicopathological significance of SOX4 expression in primary gallbladder carcinoma. Diagn Pathol. 2012;7:41. [PMID: 22510499 DOI: 10.1186/1746-1596-7-41] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
154 Qin Y, Zhang S, Gong W, Li J, Jia J, Quan Z. Adenovirus-mediated gene transfer of tissue factor pathway inhibitor-2 inhibits gallbladder carcinoma growth in vitro and in vivo. Cancer Sci 2012;103:723-30. [PMID: 22320835 DOI: 10.1111/j.1349-7006.2012.02218.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
155 Rai R, Sharma KL, Misra S, Kumar A, Mittal B. Association of adrenergic receptor gene polymorphisms in gallbladder cancer susceptibility in a North Indian population. J Cancer Res Clin Oncol. 2014;140:725-735. [PMID: 24556804 DOI: 10.1007/s00432-014-1621-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
156 Goeppert B, Truckenmueller F, Ori A, Fritz V, Albrecht T, Fraas A, Scherer D, Silos RG, Sticht C, Gretz N, Mehrabi A, Bewerunge-Hudler M, Pusch S, Bermejo JL, Dietrich P, Schirmacher P, Renner M, Roessler S. Profiling of gallbladder carcinoma reveals distinct miRNA profiles and activation of STAT1 by the tumor suppressive miRNA-145-5p. Sci Rep 2019;9:4796. [PMID: 30886199 DOI: 10.1038/s41598-019-40857-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
157 Song SP, Zhang SB, Liu R, Yao L, Hao YQ, Liao MM, Zhang YD, Li ZH. NDRG2 down-regulation and CD24 up-regulation promote tumor aggravation and poor survival in patients with gallbladder carcinoma. Med Oncol. 2012;29:1879-1885. [PMID: 22135002 DOI: 10.1007/s12032-011-0110-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
158 Utsumi M, Aoki H, Kunitomo T, Mushiake Y, Yasuhara I, Arata T, Katsuda K, Tanakaya K, Takeuchi H. Evaluation of surgical treatment for incidental gallbladder carcinoma diagnosed during or after laparoscopic cholecystectomy: single center results. BMC Res Notes 2017;10:56. [PMID: 28109315 DOI: 10.1186/s13104-017-2387-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
159 Fujiwara H, Tateishi K, Kato H, Nakatsuka T, Yamamoto K, Tanaka Y, Ijichi H, Takahara N, Mizuno S, Kogure H, Matsubara S, Nakai Y, Koike K. Isocitrate dehydrogenase 1 mutation sensitizes intrahepatic cholangiocarcinoma to the BET inhibitor JQ1. Cancer Sci 2018;109:3602-10. [PMID: 30156013 DOI: 10.1111/cas.13784] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
160 Matsushima H, Ishizaki M, Kosaka H, Matsui K, Sekimoto M, Kaibori M. A case of undifferentiated carcinoma of the gallbladder with severe inflammation and difficult preoperative chemotherapy. Clin J Gastroenterol 2022. [PMID: 35304706 DOI: 10.1007/s12328-022-01614-8] [Reference Citation Analysis]
161 Aldossary MY, Alayed AA, Amr SS, Alqahtani S, Alnahawi M, Alqahtani MS. Gallbladder cancer in Eastern Province of Saudi Arabia: A retrospective cohort study. Ann Med Surg (Lond) 2018;35:117-23. [PMID: 30294442 DOI: 10.1016/j.amsu.2018.09.020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
162 Yang XW, Yuan JM, Chen JY, Yang J, Gao QG, Yan XZ, Zhang BH, Feng S, Wu MC. The prognostic importance of jaundice in surgical resection with curative intent for gallbladder cancer. BMC Cancer. 2014;14:652. [PMID: 25187159 DOI: 10.1186/1471-2407-14-652] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
163 Hennedige TP, Neo WT, Venkatesh SK. Imaging of malignancies of the biliary tract- an update. Cancer Imaging 2014;14:14. [PMID: 25608662 DOI: 10.1186/1470-7330-14-14] [Cited by in F6Publishing: 25] [Reference Citation Analysis]
164 Gupta P, Meghashyam K, Marodia Y, Gupta V, Basher R, Das CK, Yadav TD, Irrinki S, Nada R, Dutta U. Locally advanced gallbladder cancer: a review of the criteria and role of imaging. Abdom Radiol (NY) 2021;46:998-1007. [PMID: 32945922 DOI: 10.1007/s00261-020-02756-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
165 Zhang Y, Du P, Li Y, Zhu Q, Song X, Liu S, Hao J, Liu L, Liu F, Hu Y, Jiang L, Ma Q, Lu W, Liu Y. TASP1 Promotes Gallbladder Cancer Cell Proliferation and Metastasis by Up-regulating FAM49B via PI3K/AKT Pathway. Int J Biol Sci 2020;16:739-51. [PMID: 32071545 DOI: 10.7150/ijbs.40516] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
166 Deng YL, Cheng NS, Zhang SJ, Ma WJ, Shrestha A, Li FY, Xu FL, Zhao LS. Xanthogranulomatous cholecystitis mimicking gallbladder carcinoma: An analysis of 42 cases. World J Gastroenterol 2015; 21(44): 12653-12659 [PMID: 26640342 DOI: 10.3748/wjg.v21.i44.12653] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
167 D'Andrea MR, Gill CM, Umphlett M, Tsankova NM, Fowkes M, Bederson JB, Brastianos PK, Shrivastava RK. Brain Metastases from Biliary Tract Cancers: A Case Series and Review of the Literature in the Genomic Era. Oncologist 2020;25:447-53. [PMID: 31694894 DOI: 10.1634/theoncologist.2019-0306] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
168 Matsushita S, Onishi H, Nakano K, Nagamatsu I, Imaizumi A, Hattori M, Oda Y, Tanaka M, Katano M. Hedgehog signaling pathway is a potential therapeutic target for gallbladder cancer. Cancer Sci. 2014;105:272-280. [PMID: 24438533 DOI: 10.1111/cas.12354] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
169 Knüppel M, Kubicka S, Vogel A, Malek NP, Schneider M, Papendorf F, Greten T, Wedemeyer J, Schneider A. Combination of conservative and interventional therapy strategies for intra- and extrahepatic cholangiocellular carcinoma: a retrospective survival analysis. Gastroenterol Res Pract 2012;2012:190708. [PMID: 21776251 DOI: 10.1155/2012/190708] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
170 J V, Mishra D, Meher D, Dash S, Besra K, Pattnaik N, Singh SP, Dixit M. Genetic association of MMP14 promoter variants and their functional significance in gallbladder cancer pathogenesis. J Hum Genet 2021. [PMID: 33727629 DOI: 10.1038/s10038-021-00917-x] [Reference Citation Analysis]
171 Mehra S, Panwar R, Thakur B, Yadav R, Kumar M, Singh R, Dash NR, Sahni P, Chauhan SS. Expression and Clinical Implications of Cysteine Cathepsins in Gallbladder Carcinoma. Front Oncol 2019;9:1239. [PMID: 31824841 DOI: 10.3389/fonc.2019.01239] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
172 Kilander C, Mattsson F, Lu Y, Ljung R, Lagergren J, Sadr-Azodi O. Reproductive factors and risk of biliary tract cancer in a population-based study. Acta Oncol 2015;54:1152-8. [PMID: 25752973 DOI: 10.3109/0284186X.2015.1016627] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
173 Kim K, Chie EK, Jang JY, Kim SW, Han SW, Oh DY, Im SA, Kim TY, Bang YJ, Ha SW. Postoperative chemoradiotherapy for gallbladder cancer. Strahlenther Onkol. 2012;188:388-392. [PMID: 22402869 DOI: 10.1007/s00066-012-0074-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
174 Kawamoto M, Onishi H, Ozono K, Yamasaki A, Imaizumi A, Kamakura S, Nakano K, Oda Y, Sumimoto H, Nakamura M. Tropomyosin-related kinase B mediated signaling contributes to the induction of malignant phenotype of gallbladder cancer. Oncotarget 2017;8:36211-24. [PMID: 28423707 DOI: 10.18632/oncotarget.16063] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
175 Li M, Liu F, Zhang F, Zhou W, Jiang X, Yang Y, Qu K, Wang Y, Ma Q, Wang T, Bai L, Wang Z, Song X, Zhu Y, Yuan R, Gao Y, Liu Y, Jin Y, Li H, Xiang S, Ye Y, Zhang Y, Jiang L, Hu Y, Hao Y, Lu W, Chen S, Gu J, Zhou J, Gong W, Zhang Y, Wang X, Liu X, Liu C, Liu H, Liu Y, Liu Y. Genomic ERBB2/ERBB3 mutations promote PD-L1-mediated immune escape in gallbladder cancer: a whole-exome sequencing analysis. Gut 2019;68:1024-33. [PMID: 29954840 DOI: 10.1136/gutjnl-2018-316039] [Cited by in Crossref: 67] [Cited by in F6Publishing: 58] [Article Influence: 22.3] [Reference Citation Analysis]
176 Lee MH, Gao YT, Huang YH, McGee EE, Lam T, Wang B, Shen MC, Rashid A, Pfeiffer RM, Hsing AW, Koshiol J. A Metallomic Approach to Assess Associations of Serum Metal Levels With Gallstones and Gallbladder Cancer. Hepatology 2020;71:917-28. [PMID: 31318976 DOI: 10.1002/hep.30861] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
177 Chen C, Geng Z, Shen H, Song H, Zhao Y, Zhang G, Li W, Ma L, Wang L. Long-Term Outcomes and Prognostic Factors in Advanced Gallbladder Cancer: Focus on the Advanced T Stage. PLoS One 2016;11:e0166361. [PMID: 27846279 DOI: 10.1371/journal.pone.0166361] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 5.7] [Reference Citation Analysis]
178 Piccolo G, Piozzi GN. Laparoscopic Radical Cholecystectomy for Primary or Incidental Early Gallbladder Cancer: The New Rules Governing the Treatment of Gallbladder Cancer. Gastroenterol Res Pract 2017;2017:8570502. [PMID: 28690639 DOI: 10.1155/2017/8570502] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
179 Huang D, Joo H, Song N, Cho S, Kim W, Shin A. Association between gallstones and the risk of biliary tract cancer: a systematic review and meta-analysis. Epidemiol Health 2021;43:e2021011. [PMID: 33541011 DOI: 10.4178/epih.e2021011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
180 Letelier P, Brebi P, Tapia O, Roa JC. DNA promoter methylation as a diagnostic and therapeutic biomarker in gallbladder cancer. Clin Epigenetics. 2012;4:11. [PMID: 22794276 DOI: 10.1186/1868-7083-4-11] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
181 Nigam J, Chandra A, Kazmi HR, Parmar D, Singh D, Gupta V, M N. Expression of survivin mRNA in gallbladder cancer: a diagnostic and prognostic marker? Tumour Biol. 2014;35:9241-9246. [PMID: 24935470 DOI: 10.1007/s13277-014-2200-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
182 Chen M, Lin J, Cao J, Zhu H, Zhang B, Wu A, Cai X. Development and validation of a nomogram for survival benefit of lymphadenectomy in resected gallbladder cancer. Hepatobiliary Surg Nutr. 2019;8:480-489. [PMID: 31673537 DOI: 10.21037/hbsn.2019.03.02] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
183 Weickert U, Jakobs R, Riemann J. Stellenwert der endoskopischen retrograden Cholangiopankreatographie, der perkutan-transhepatischen Cholangiographie, der Endosonographie und der endoluminalen Sonographie in der Behandlung des Gallenblasen- und des Gallengangkarzinoms. Visc Med 2004;20:265-71. [DOI: 10.1159/000083011] [Reference Citation Analysis]
184 Mhatre S, Lacey B, Sherliker P, Chatterjee N, Rajaraman P, Goel M, Patkar S, Ostwal V, Patil P, Shrikhande SV, Chitkara G, Badwe R, Lewington S, Dikshit R. Reproductive factors and gall-bladder cancer, and the effect of common genetic variants on these associations: a case-control study in India. Int J Epidemiol 2021:dyab197. [PMID: 34550362 DOI: 10.1093/ije/dyab197] [Reference Citation Analysis]
185 Subbannayya T, Leal-Rojas P, Barbhuiya MA, Raja R, Renuse S, Sathe G, Pinto SM, Syed N, Nanjappa V, Patil AH, Garcia P, Sahasrabuddhe NA, Nair B, Guerrero-Preston R, Navani S, Tiwari PK, Santosh V, Sidransky D, Prasad TS, Gowda H, Roa JC, Pandey A, Chatterjee A. Macrophage migration inhibitory factor - a therapeutic target in gallbladder cancer. BMC Cancer 2015;15:843. [PMID: 26530123 DOI: 10.1186/s12885-015-1855-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
186 Butte JM, Marín L, Meneses M, De la Fuente H, Pruzzo R, Redondo F, Parada H, Amaral H, Waugh E. Thyroid metastases from gallbladder cancer. J Gastrointest Surg 2009;13:1389-91. [PMID: 19023633 DOI: 10.1007/s11605-008-0743-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
187 Pandey SN, Dixit M, Choudhuri G, Mittal B. Lipoprotein receptor associated protein (LRPAP1) insertion/deletion polymorphism: association with gallbladder cancer susceptibility. Int J Gastrointest Cancer. 2006;37:124-128. [PMID: 17987404 DOI: 10.1007/s12029-007-9002-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
188 Washiro M, Ohtsuka M, Kimura F, Shimizu H, Yoshidome H, Sugimoto T, Seki N, Miyazaki M. Upregulation of topoisomerase IIalpha expression in advanced gallbladder carcinoma: a potential chemotherapeutic target. J Cancer Res Clin Oncol. 2008;134:793-801. [PMID: 18204862 DOI: 10.1007/s00432-007-0348-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
189 Chen K, Zhu P, Chen W, Luo K, Shi XJ, Zhai W. Melatonin inhibits proliferation, migration, and invasion by inducing ROS-mediated apoptosis via suppression of the PI3K/Akt/mTOR signaling pathway in gallbladder cancer cells. Aging (Albany NY) 2021;13:22502-15. [PMID: 34580235 DOI: 10.18632/aging.203561] [Reference Citation Analysis]
190 Heavey SF, Roeland EJ, Tipps AM, Datnow B, Sicklick JK. Rapidly progressive subcutaneous metastases from gallbladder cancer: insight into a rare presentation in gastrointestinal malignancies. J Gastrointest Oncol 2014;5:E58-64. [PMID: 25083307 DOI: 10.3978/j.issn.2078-6891.2014.023] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
191 Zong H, Zhou H, Xiang Y, Wu G. miR-125b suppresses cellular proliferation by targeting c-FLIP in gallbladder carcinoma. Oncol Lett 2019;18:6822-8. [PMID: 31788125 DOI: 10.3892/ol.2019.11000] [Reference Citation Analysis]
192 Gupta A, Sharma A, Yadav A, Rastogi N, Agrawal S, Kumar A, Kumar V, Misra S, Mittal B. Evaluation of miR-27a, miR-181a, and miR-570 genetic variants with gallbladder cancer susceptibility and treatment outcome in a North Indian population. Mol Diagn Ther. 2015;19:317-327. [PMID: 26288960 DOI: 10.1007/s40291-015-0159-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
193 Rejab H, Kridis WB, Triki H, Foued Frikha M, Khanfir A, Frikha M, Mzali R. An unusual case of gallbladder cancer. Acta Clin Belg 2015;70:382-3. [PMID: 26364562 DOI: 10.1179/2295333715Y.0000000033] [Reference Citation Analysis]
194 Chen C, Zhang R, Ma L, Li Q, Zhao YL, Zhang GJ, Zhang D, Li WZ, Cao S, Wang L, Geng ZM. Neuropilin-1 is up-regulated by cancer-associated fibroblast-secreted IL-8 and associated with cell proliferation of gallbladder cancer. J Cell Mol Med 2020;24:12608-18. [PMID: 32951327 DOI: 10.1111/jcmm.15825] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
195 Mohri D, Ijichi H, Miyabayashi K, Takahashi R, Kudo Y, Sasaki T, Asaoka Y, Tanaka Y, Ikenoue T, Tateishi K, Tada M, Isayama H, Koike K. A potent therapeutics for gallbladder cancer by combinatorial inhibition of the MAPK and mTOR signaling networks. J Gastroenterol 2016;51:711-21. [PMID: 26614007 DOI: 10.1007/s00535-015-1145-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
196 Shukla PJ, Barreto SG, Arya S, Shrikhande SV, Hawaldar R, Purandare N, Rangarajan V. Does PET-CT scan have a role prior to radical re-resection for incidental gallbladder cancer? HPB (Oxford). 2008;10:439-445. [PMID: 19088931 DOI: 10.1080/13651820802286910] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
197 Shukla PJ, Barreto SG. Systematic review: should routine resection of the extra-hepatic bile duct be performed in gallbladder cancer? Saudi J Gastroenterol. 2010;16:161-167. [PMID: 20616410 DOI: 10.4103/1319-3767.65184] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
198 Nakamura H, Arai Y, Totoki Y, Shirota T, Elzawahry A, Kato M, Hama N, Hosoda F, Urushidate T, Ohashi S, Hiraoka N, Ojima H, Shimada K, Okusaka T, Kosuge T, Miyagawa S, Shibata T. Genomic spectra of biliary tract cancer. Nat Genet. 2015;47:1003-1010. [PMID: 26258846 DOI: 10.1038/ng.3375] [Cited by in Crossref: 474] [Cited by in F6Publishing: 519] [Article Influence: 67.7] [Reference Citation Analysis]
199 Woo SM, Lee SH, Yoo JW, Yang KY, Seo JG, Park JK, Hwang JH, Lee WJ, Ryu JK, Kim YT, Yoon YB. A Multicenter Phase II Trial of Gemcitabine Plus Oxaliplatin in Unresectable Gallbladder Cancer. Gut Liver 2013;7:594-8. [PMID: 24073318 DOI: 10.5009/gnl.2013.7.5.594] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
200 Kuipers H, de Savornin Lohman EAJ, van Dooren M, Braat AE, Daams F, van Dam R, Erdmann JI, Hagendoorn J, Hoogwater FJH, Groot Koerkamp B, van Gulik TM, de Reuver PR, de Boer MT. Extended Resections for Advanced Gallbladder Cancer: Results from a Nationwide Cohort Study. Ann Surg Oncol 2021;28:835-43. [PMID: 32696306 DOI: 10.1245/s10434-020-08858-z] [Reference Citation Analysis]
201 Goetze TO. Gallbladder carcinoma: Prognostic factors and therapeutic options. World J Gastroenterol 2015; 21(43): 12211-12217 [PMID: 26604631 DOI: 10.3748/wjg.v21.i43.12211] [Cited by in CrossRef: 120] [Cited by in F6Publishing: 103] [Article Influence: 17.1] [Reference Citation Analysis]
202 Kim WS, Choi DW, You DD, Ho CY, Heo JS, Choi SH. Risk factors influencing recurrence, patterns of recurrence, and the efficacy of adjuvant therapy after radical resection for gallbladder carcinoma. J Gastrointest Surg. 2010;14:679-687. [PMID: 20094817 DOI: 10.1007/s11605-009-1140-z] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 3.1] [Reference Citation Analysis]
203 Chen Y, Yan J, Yu S, Wang X, Zheng Q. Over-expression of beclin-1 in gallbladder carcinoma and its relationship with prognosis. Contemp Oncol (Pozn) 2014;18:171-6. [PMID: 25520576 DOI: 10.5114/wo.2014.41395] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
204 Borena W, Edlinger M, Bjørge T, Häggström C, Lindkvist B, Nagel G, Engeland A, Stocks T, Strohmaier S, Manjer J, Selmer R, Tretli S, Concin H, Hallmans G, Jonsson H, Stattin P, Ulmer H. A prospective study on metabolic risk factors and gallbladder cancer in the metabolic syndrome and cancer (Me-Can) collaborative study. PLoS One 2014;9:e89368. [PMID: 24586723 DOI: 10.1371/journal.pone.0089368] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
205 Sharma KL, Agarwal A, Misra S, Kumar A, Kumar V, Mittal B. Association of genetic variants of xenobiotic and estrogen metabolism pathway (CYP1A1 and CYP1B1) with gallbladder cancer susceptibility. Tumor Biol 2014;35:5431-9. [DOI: 10.1007/s13277-014-1708-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
206 Faridi MS, Jaiswal MS, Goel SK. Expression of CCK Receptors in Carcinoma Gallbladder and Cholelithiasis: A Pilot Study. J Clin Diagn Res. 2015;9:PC04-PC07. [PMID: 26393162 DOI: 10.7860/jcdr/2015/12697.6152] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
207 Fuks D, Borgaonkar V, Deshpande S, Deshpande V, Mouly C, Borgaonkar V, Mauvais F, Jadhav V, Regimbeau JM. Gallbladder cancer revealed by an endobiliary tumor thrombus. Indian J Surg 2013;75:442-5. [PMID: 24426643 DOI: 10.1007/s12262-012-0774-3] [Reference Citation Analysis]
208 Kumar N, Singhal P, Agarwal A, Khan MA. Cytopathological diagnosis of gallbladder mass and mural thickening based on imaging findings: A prospective study of 51 cases. J Cytol 2015;32:234-7. [PMID: 26811570 DOI: 10.4103/0970-9371.171231] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
209 Mondal SK, Bhattacharjee D, Mandal PK, Biswas S. Histopathological study of gallbladder carcinoma and its mimics with role of carcinoembryonic antigen immunomarker in resolving diagnostic difficulties. Indian J Med Paediatr Oncol 2017;38:411-5. [PMID: 29333003 DOI: 10.4103/ijmpo.ijmpo_230_15] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
210 Yang XW, Chen JY, Wen ZJ, Li YL, Wang FY, Li L, Yang J, Yang PH, Zhang BH, Shen F. Effect of preoperative jaundice on long-term prognosis of gallbladder carcinoma with radical resection. World J Surg Oncol 2020;18:239. [PMID: 32891147 DOI: 10.1186/s12957-020-02015-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
211 Li X, Liu Y, Wang Y, Ruan C, Wang H, Liang X, Sun Y, Hu Z. The influence of marital status on survival of gallbladder cancer patients: a population-based study. Sci Rep 2017;7:5322. [PMID: 28706207 DOI: 10.1038/s41598-017-05545-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
212 Li K, Tang J, Hou Y. LncRNA GATA6-AS inhibits cancer cell migration and invasion in gallbladder cancer by downregulating miR-421. Onco Targets Ther 2019;12:8047-53. [PMID: 31632058 DOI: 10.2147/OTT.S212231] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
213 Barreto SG, Haga H, Shukla PJ. Hormones and gallbladder cancer in women. Indian J Gastroenterol. 2009;28:126-130. [PMID: 19937419 DOI: 10.1007/s12664-009-0046-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
214 Du X, Wu T, Lu J, Zang L, Song N, Yang T, Zhao H, Wang S. Decreased expression of chromodomain helicase DNA-binding protein 5 is an unfavorable prognostic marker in patients with primary gallbladder carcinoma. Clin Transl Oncol. 2013;15:198-204. [PMID: 22855185 DOI: 10.1007/s12094-012-0903-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
215 Dorobisz T, Dorobisz K, Chabowski M, Pawłowski W, Janczak D, Patrzałek D, Janczak D. Incidental gallbladder cancer after cholecystectomy: 1990 to 2014. Onco Targets Ther 2016;9:4913-6. [PMID: 27540304 DOI: 10.2147/OTT.S106580] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
216 Singh T, Gupta P. Role of Dual-Energy Computed Tomography in Gallbladder Disease: A Review. Journal of Gastrointestinal and Abdominal Radiology. [DOI: 10.1055/s-0042-1743173] [Reference Citation Analysis]
217 Miwa T, Nagata T, Kojima H, Sekine S, Okumura T. Isoform switch of CD44 induces different chemotactic and tumorigenic ability in gallbladder cancer. Int J Oncol 2017;51:771-80. [PMID: 28677740 DOI: 10.3892/ijo.2017.4063] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
218 Huang X, He M, Huang S, Lin R, Zhan M, Yang D, Shen H, Xu S, Cheng W, Yu J, Qiu Z, Wang J. Circular RNA circERBB2 promotes gallbladder cancer progression by regulating PA2G4-dependent rDNA transcription. Mol Cancer 2019;18:166. [PMID: 31752867 DOI: 10.1186/s12943-019-1098-8] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 15.7] [Reference Citation Analysis]
219 Yang L, Gao Q, Wu X, Feng F, Xu K. Long noncoding RNA HEGBC promotes tumorigenesis and metastasis of gallbladder cancer via forming a positive feedback loop with IL-11/STAT3 signaling pathway. J Exp Clin Cancer Res 2018;37:186. [PMID: 30086773 DOI: 10.1186/s13046-018-0847-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
220 Kim M, Kim H, Han Y, Sohn H, Kang JS, Kwon W, Jang JY. Prognostic Value of Carcinoembryonic Antigen (CEA) and Carbohydrate Antigen 19-9 (CA 19-9) in Gallbladder Cancer; 65 IU/mL of CA 19-9 Is the New Cut-Off Value for Prognosis. Cancers (Basel) 2021;13:1089. [PMID: 33806265 DOI: 10.3390/cancers13051089] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
221 Signorelli C, Marrucci E, Cristi E, Pastorelli A, Cardello P, Chilelli MG, Zampaletta C, Ruggeri EM. Colon metastasis from recurrent gallbladder cancer: a case report. AME Case Rep 2021;5:21. [PMID: 34312600 DOI: 10.21037/acr-20-167] [Reference Citation Analysis]
222 Xu LN, Zou SQ, Wang JM. Action and mechanism of Fas and Fas ligand in immune escape of gallbladder carcinoma. World J Gastroenterol 2005; 11(24): 3719-3723 [PMID: 15968727 DOI: 10.3748/wjg.v11.i24.3719] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
223 Zhai T, Zhang X, Hei Z, Jin L, Han C, Ko AT, Yu X, Wang J. Isorhamnetin Inhibits Human Gallbladder Cancer Cell Proliferation and Metastasis via PI3K/AKT Signaling Pathway Inactivation. Front Pharmacol 2021;12:628621. [PMID: 33679411 DOI: 10.3389/fphar.2021.628621] [Reference Citation Analysis]
224 Ichimiya S, Onishi H, Nagao S, Koga S, Sakihama K, Nakayama K, Fujimura A, Oyama Y, Imaizumi A, Oda Y, Nakamura M. GLI2 but not GLI1/GLI3 plays a central role in the induction of malignant phenotype of gallbladder cancer. Oncol Rep 2021;45:997-1010. [PMID: 33650666 DOI: 10.3892/or.2021.7947] [Reference Citation Analysis]
225 Graff AE, Lewis SL, Bear JR, Van Echo DC, Dainer HM. Gallbladder Carcinoma, the Difficulty of Early Detection: A Case Report. Cureus 2016;8:e493. [PMID: 27014527 DOI: 10.7759/cureus.493] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
226 Mekeel KL, Hemming AW. Surgical management of gallbladder carcinoma: a review. J Gastrointest Surg. 2007;11:1188-1193. [PMID: 17712596 DOI: 10.1007/s11605-007-0115-1] [Cited by in Crossref: 55] [Cited by in F6Publishing: 41] [Article Influence: 3.7] [Reference Citation Analysis]
227 Du S, Zhu L, Sang X, Mao Y, Lu X, Zhong S, Huang J. Gallbladder carcinoma post gallbladder-preserving cholecystolithotomy: a case report. Hepatobiliary Surg Nutr 2012;1:61-3. [PMID: 24570906 DOI: 10.3978/j.issn.2304-3881.2012.07.01] [Reference Citation Analysis]
228 Al Khader A, Nsour E, Alrubaye A, Al-Saghbini M. Poorly Cohesive Cell Carcinoma of the Gallbladder with Signet Rings and Neuroendocrine-Like Morphology: A Rare Incidental Histopathological Diagnosis with Lessons to Learn. Am J Case Rep 2019;20:1558-61. [PMID: 31644525 DOI: 10.12659/AJCR.919095] [Reference Citation Analysis]
229 Hu J, Cao J, Jin R, Zhang B, Topatana W, Juengpanich S, Li S, Chen T, Lu Z, Cai X, Chen M. Inhibition of AMPK/PFKFB3 mediated glycolysis synergizes with penfluridol to suppress gallbladder cancer growth. Cell Commun Signal 2022;20:105. [PMID: 35842652 DOI: 10.1186/s12964-022-00882-8] [Reference Citation Analysis]